| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3014162 | Revista Española de Cardiología | 2006 | 8 Pages |
Abstract
Intracoronary administration of an abciximab bolus did not appear to be less safe or effective than intravenous administration. Less postprocedural myocardial damage was observed in the intracoronary bolus group.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
José G. Galache Osuna, Juan Sánchez-Rubio, Isabel Calvo, José A. Diarte, Antonela Lukic, Luis J. Placer,